Downregulation of Treg cells with higher expression of LFA-3 in both Hashimoto’s and Graves’ disease groups could suggest their role in pathogenesis of these autoimmune diseases and may open therapeutic hope for those patients. This evidence concerns the gene CD58 and Graves disease.